{
    "code": "51058827",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=51058827",
    "time": "2021-12-17 06:23:27",
    "許可證字號": "衛部藥製字第058827號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/09\/09",
    "發證\/登錄日期": "104\/09\/09",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY05105882700",
    "中文品名": "好佑得凍晶注射劑100毫克",
    "英文品名": "Pemeda Lyophilized Powder for Injection 100mg",
    "適應症": "1.Pemetrexed併用Cisplatin是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第一線化療用藥。2.Pemetrexed單一藥物是局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。\r\n3.Pemetrexed單一藥物是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第二線治療用藥。4.Pemetrexed與Cisplatin併用於治療惡性肋膜間質細胞瘤。",
    "劑型": "243凍晶注射劑",
    "包裝": "100毫克玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "Pemetrexed disodium 2.5 hydrate",
    "限制項目": "01國　產 24監視期滿學名藥",
    "申請商名稱": "0903620200  南光化學製藥股份有限公司",
    "申請商地址": "臺南市新化區全興里中山路1001號、1001之1號",
    "主製造廠": [
        {
            "": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1004002420",
            "成分名稱": "Pemetrexed disodium 2.5 hydrate",
            "含量描述": "(Hemi Pentahydrate) (eq. to Pemetrexed 100mg)",
            "含量": "120.8000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "510588270001_121214-00-104-10-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058827&Seq=001&Type=9"
        },
        {
            "title": "51058827-104-10-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058827&Seq=002&Type=8"
        }
    ]
}